Possibly Les has decided it's not worth wasting any press releases or news developments during what remains of '08. No sense getting in the way of ANY reason for anybody to sell any more in the next two weeks. Best to wait for a clean slate in '09 and a market that's not distracted by year end house-cleaning and holiday distractions. Any good stuff - including some insider purchasing - would play better early next year.
Sense....lets not forget that though they may well be adding those other three to Dengue this spring, you only are awarded the actual voucher once your drug has gotten FDA approval. Now, if Ebola and Marburg are added this spring, and as we will then be doing the final testing for those FDA approvals ... that would be a fantastic thing! Then we'd be guaranteed the two vouchers relatively quickly if all goes well. If those two diseases are not added, we'll have to rely on dengue - which is coming up much more slowly.
agreed; missed milestone for DMD IV to start in Q4 (it is slated to start in Jan at 2 sites in UK); so don't expect any dec announcements at this point due to lack of market attention in late dec. Will be looking for the Q1 gov "contract" that they claim will take them to Q3 pharm partnership for DMD - otherwise we're facing another PIPE(?) mid 2009 as the only item for steady revenue stream will be cook in 2010.